NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer

被引：0
|
作者：
Szender, J. B. [1 ]
Papanicolau-Sengos, A. [2 ]
Eng, K. [1 ]
Miliotto, A. J. [1 ]
Lugade, A. [1 ]
Gnjatic, S. [3 ]
Matsuzaki, J. [1 ]
Odunsi, K. [1 ]
机构：
[1] Roswell Park Canc Inst, Buffalo, NY 14263 USA
[2] OmniSeq, Buffalo, NY USA
[3] Elmhurst Hosp Ctr, Icahn Sch Med Mt Sinai, Elmhurst, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [31] Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
    Chu, Hin Lun
    Cornelissen, Bart
    Jackson, Mark
    Vallis, Katherine
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [32] NY-ESO-1 as a predictive and prognostic marker in NSCLC
    John, Tom
    Russell, Prudence
    Barnett, Stephen
    Wainer, Zoe
    White, Shane
    Mitchell, Paul
    Walkiewicz, Marzena
    Boutros, Paul C.
    Starmans, Maud H. W.
    Chen, Yao-Tseng
    Wright, Gavin
    Knight, Simon
    Cebon, Jonathan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma
    Nakamura, Shinichiro
    Nouso, Kazuhiro
    Noguchi, Yuji
    Higashi, Toshihiro
    Ono, Toshiro
    Jungbluth, Achim
    Chen, Yao-Tseng
    Old, Lloyd J.
    Nakayama, Eiichi
    Shiratori, Yasushi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (08) : 1281 - 1285
  • [34] Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment
    Zhou, Hong
    Ma, Yipeng
    Liu, Fenglan
    Li, Bin
    Qiao, Dongjuan
    Ren, Peigen
    Wang, Mingjun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis
    Smith, Stephen M.
    Iwenofu, O. Hans
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (04)
  • [36] NY-ESO-1 protein expression and humoral immune responses in prostate cancer
    Fosså, A
    Berner, A
    Fosså, SD
    Hernes, E
    Gaudernack, G
    Smeland, EB
    PROSTATE, 2004, 59 (04): : 440 - 447
  • [37] NY-ESO-1 protein cancer vaccine with TLR 3 and 4 agonists
    Takeoka, Tomohira
    Nagase, Hirotsugu
    Miyazaki, Yasuhiro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Makino, Tomoki
    Yamasaki, Makoto
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    Wada, Hisashi
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [38] WT1, NY-ESO-1 AND PRAME EXPRESSION IN BREAST CANCER SUBTYPES
    Esposito, A.
    Bagnardi, V.
    Criscitiello, C.
    Gelao, L.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2014, 25 : 18 - 18
  • [39] Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
    Odunsi, Kunle
    Matsuzaki, Junko
    Karbach, Julia
    Neumann, Antje
    Mhawech-Fauceglia, Paulette
    Miller, Austin
    Beck, Amy
    Morrison, Carl D.
    Ritter, Gerd
    Godoy, Heidi
    Lele, Shashikant
    duPont, Nefertiti
    Edwards, Robert
    Shrikant, Protul
    Old, Lloyd J.
    Gnjatic, Sacha
    Jaeger, Elke
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (15) : 5797 - 5802
  • [40] Clinicopathological Assessment of Cancer/Testis Antigens NY-ESO-1 and MAGE-A4 in Highly Aggressive Soft Tissue Sarcomas
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Ito, Tomohiko
    Akagi, Masao
    DIAGNOSTICS, 2022, 12 (03)
12345